The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions

KAYHAN S., Gumus A., CINARKA H., Murat N., Yilmaz A., Bedir R., ...More

JOURNAL OF THORACIC DISEASE, vol.5, no.5, pp.634-640, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 5 Issue: 5
  • Publication Date: 2013
  • Doi Number: 10.3978/j.issn.2072-1439.2013.09.19
  • Journal Name: JOURNAL OF THORACIC DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.634-640
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Background and objective: Recent evidence suggests that YKL-40 is a relatively new biomarker of inflammation and it is involved in the pathogenesis of several pulmonary diseases. Details of serum and pleural YKL-40 in pleural effusions however, remain unknown. We aimed to assess whether serum and pleural YKL-40 is an accurate biomarker of pleural effusions.